HIDRADENITIS SUPPURATIVA

This study tested a drug called bimekizumab in 509 adults with moderate to severe hidradenitis suppurativa, a chronic skin condition that causes painful lumps under the skin. The goal was to see if the drug could reduce the number of abscesses and inflamed bumps by at least 50% a…

This study tested a medicine called spesolimab in 209 adults with moderate to severe hidradenitis suppurativa (HS), a chronic skin condition causing painful lumps and tunnels. Participants received different doses of spesolimab or a placebo for about a year. The goal was to see i…

This study tested a drug called bimekizumab in 505 adults with moderate to severe hidradenitis suppurativa, a chronic skin condition that causes painful lumps. Participants received either the drug or a placebo. The main goal was to see if the drug could reduce skin lesions by at…

This study tested the safety and effectiveness of tofacitinib, a drug that blocks certain immune signals, for treating skin conditions like eczema and psoriasis in people with Down syndrome. 47 adolescents and adults took part. The goal was to see if the drug could improve these …

This study tested a new drug called SAR442970 in 86 adults with moderate to severe hidradenitis suppurativa (HS), a chronic skin condition causing painful lumps. The goal was to see if the drug reduces inflammation and flare-ups better than a placebo. Participants received either…

This study looked at the long-term safety and effectiveness of the drug spesolimab for adults with hidradenitis suppurativa (HS), a painful skin condition. Participants who had already completed a previous spesolimab trial received injections every two weeks for two years. The go…

This study tested a medicine called spesolimab in 52 adults with moderate to severe hidradenitis suppurativa, a chronic skin disease causing painful lumps and boils. Participants were randomly assigned to receive either spesolimab or a placebo (dummy treatment) as infusions and i…

This study looked at whether mindfulness training can help people with hidradenitis suppurativa (HS) feel better day-to-day. HS is a painful skin condition that can seriously affect quality of life. Researchers enrolled 37 adults with HS and measured changes in their quality of l…

This study tested an investigational drug called AVTX-009 in 253 adults with moderate to severe hidradenitis suppurativa, a chronic skin condition causing painful lumps. The goal was to see if the drug reduces skin lesions better than a placebo. Participants received either AVTX-…

This study tested a drug called imsidolimab in 149 people with hidradenitis suppurativa, a chronic skin condition causing painful lumps. Participants received either the drug or a placebo for 16 weeks. The main goal was to see if the drug reduced the number of abscesses and infla…

This study involved 324 adults with conditions like Crohn's disease, arthritis, or psoriasis who switched from a standard to a higher-concentration adalimumab injection. Researchers measured injection site pain and how well patients stuck with the new treatment over 180 days. The…

This study tested whether a special bioelectric dressing can improve healing of wounds after a surgical procedure called de-roofing for hidradenitis suppurativa (HS). Twelve adults with HS took part. Researchers measured how fast the wounds healed and how many people healed compl…

This study tested an experimental drug called ATI-450 in 95 people with moderate to severe hidradenitis suppurativa (HS), a painful skin condition that causes boils and abscesses. Participants received either ATI-450 or a placebo for 12 weeks. The main goal was to see if the drug…

This study looked at skin samples from 20 people with moderate to severe hidradenitis suppurativa (HS) who had surgery. Researchers measured different inflammatory proteins in the lab to better understand what causes the disease and why it comes back. The goal was to gather knowl…

This study surveyed 67 adults with hidradenitis suppurativa (a chronic skin condition causing painful lumps and sores) to better understand how the disease impacts their quality of life. Researchers also tested a new tool that lets patients rate their own disease severity using p…